Hackensack Meridian Health Oncology

Machine Learning Helps ID Patients Who May Not Respond to Certain Diffuse Large B-Cell lymphoma Treatments in Hackensack University Medical Center Study

Transcriptome Analysis Gives Insight on Post-Treatment Survival Characteristics to Show Who May Not Respond Well to Traditional Drug Approaches

CANDOR Study Gives Hope for Relapsed and Refractory Myeloma at Hackensack University Medical Center

Phase III Trial Confirms Carfilzomib and Dexamethasone as Emerging Standard of Care

Hackensack University Medical Center Investigates Safety and Efficacy of Promising Precision Therapy in FIGHT-101 Trial

Marks First In-Human Study of FGFR 1-3 Inhibitor Pemigatinib

Today’s Most Important Oncology Papers Identified by Hackensack University Medical Center Leader

John Theurer Cancer Center Chairman Andre Goy Selects Field’s Top Four Publications Shifting the Direction of Cancer Care

GPS Like Technology
GPS-Style Ion Lung Cancer Tool Now at Hackensack University Medical Center

Guidance Technology Brings Precision and Efficiency to Nodule Detection and Removal

ZUMA-7 Study Shows Value of CAR T-Cell Therapy as Second-Line Treatment for Relapsed Large B-Cell Lymphoma

John Theurer Cancer Center Investigators Participate in Study Set to Shift 40-Year Standard of Care

Dose Ranging
Ponatinib Dose-Ranging Study Pinpoints Optimal Dose for Treating Chronic Myeloid Leukemia

Phase 2 Trial Identifies Dosage Strategy to Maximize Efficacy and Reduce Risk of Arterial Occlusions

First CAR T Therapy to Treat Multiple Myeloma Offers Hope to Patients No Longer Responsive to Standard Therapy

FDA Approves Abecma Following Phase II KarMMA Trial at Hackensack Meridian John Theurer Cancer Center

Brexu-cel Clinical Practice Safety Report by Lymphoma CAR T Consortium

Hackensack University Medical Center Among Centers Reporting Positive Results at American Society of Hematology Meeting

Hackensack University Medical Center Surgeon Offers Tips for Patient Compliance with New Colorectal Cancer Screening Age

Screening Options and Common Questions to Anticipate with New Screening Start Age of 45

Hackensack Meridian Health Genomic Profiling Lab Advances Blood Cancer and Solid Tumor Care

Partnership with Genomic Testing Cooperative Helps Oncologists Precisely Diagnose Cancer and Develop Treatment Plans

Promising Immunotherapy Explored in CAR T-Cell Trials at John Theurer Cancer Center at Hackensack University Medical Center

Successful Remission Achieved for Recurring Multiple Myeloma Patient Participating in CAR T-Cell Trial

Lymphoma in Remission Thanks to New Form of Immunotherapy at Hackensack University Medical Center

Mantle Cell Lymphoma Patient Case Study Demonstrates Powerful Impact of CAR T-Cell Therapy

Cancer Research Breakthroughs at Hackensack University Medical Center

Roundup of the Most Promising Clinical and Lab Discoveries Fueled by the Center for Discovery & Innovation

Hackensack University Medical Center Breast Surgeons Demonstrate New Technology for Marking Location of Cancerous Lymph Nodes

Tool Shown Accurate and Effective in Making Procedure More Comfortable for Patients

We use cookies to improve your site experience. By using this site,
you agree to our Terms & Conditions. Also, please read our Privacy Policy.
Accept All Cookies